Literature DB >> 1691411

The renin-angiotensin system: importance in physiology and pathology.

C M Ferrario1.   

Abstract

In recent years, the role of the renin-angiotensin system (RAS) in the development of hypertension has been investigated extensively. Studies have shown that there are actually two systems: a tissue and a circulating RAS. The control of hypertension is focused primarily in the RAS in the cardiovascular system and the brain. By manipulating the RAS with angiotensin converting enzyme (ACE) inhibitors, researchers have learned that the cardiovascular neuronal centers in the brain have receptor sites for the actions of angiotensin II (Ang II). Receptors for Ang II are found in the medulla oblongata in neurons involved in the regulation of baroceptor activity. Since studies in both animals and hypertensive patients indicate that ACE inhibitors reduced sympathetic activity and enhanced baroceptor sensitivity, it is possible that the primary hypotensive mechanism of these agents is through blockage of Ang II formation in the cardiovascular centers of the brain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691411

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  17 in total

Review 1.  Direct renin inhibition: an analysis of possible benefits.

Authors:  Brian K Dockery; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

2.  Frusemide inhibits angiotensin II-induced contraction on human vascular smooth muscle.

Authors:  F Stanke; P Devillier; D Bréant; O Chavanon; C Sessa; G Bricca; G Bessard
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 3.  Pathologic consequences of increased angiotensin II activity.

Authors:  C M Ferrario; J M Flack
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 4.  ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.

Authors:  A C Simões e Silva; K D Silveira; A J Ferreira; M M Teixeira
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

5.  Angiotensin II induces membrane trafficking of natively expressed transient receptor potential vanilloid type 4 channels in hypothalamic 4B cells.

Authors:  Ashwini Saxena; Martha Bachelor; Yong H Park; Flavia R Carreno; T Prashant Nedungadi; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-30       Impact factor: 3.619

6.  Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.

Authors:  Navneet Kaur; Amardeep Kaur; Yogita Bansal; Dhvanit I Shah; Gulshan Bansal; Manjeet Singh
Journal:  Bioorg Med Chem       Date:  2008-10-29       Impact factor: 3.641

7.  New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.

Authors:  Anderson J Ferreira; Tatiane M Murça; Rodrigo A Fraga-Silva; Carlos Henrique Castro; Mohan K Raizada; Robson A S Santos
Journal:  Int J Hypertens       Date:  2012-01-26       Impact factor: 2.420

8.  Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats.

Authors:  Giselle Foureaux; Juçara Ribeiro Franca; José Carlos Nogueira; Gustavo de Oliveira Fulgêncio; Tatiana Gomes Ribeiro; Rachel Oliveira Castilho; Maria Irene Yoshida; Leonardo Lima Fuscaldi; Simone Odília Antunes Fernandes; Valbert Nascimento Cardoso; Sebastião Cronemberger; André Augusto Gomes Faraco; Anderson José Ferreira
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

9.  Angiotensin Converting Enzyme Regulates Cell Proliferation and Migration.

Authors:  Erika Costa de Alvarenga; Matheus de Castro Fonseca; Clarissa Coelho Carvalho; Rodrigo Machado Florentino; Andressa França; Eveline Matias; Paola Bianchi Guimarães; Carolina Batista; Valder Freire; Adriana Karaoglanovic Carmona; João Bosco Pesquero; Ana Maria de Paula; Giselle Foureaux; Maria de Fatima Leite
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

10.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure.

Authors:  Katalin Úri; Miklós Fagyas; Ivetta Mányiné Siket; Attila Kertész; Zoltán Csanádi; Gábor Sándorfi; Marcell Clemens; Roland Fedor; Zoltán Papp; István Édes; Attila Tóth; Erzsébet Lizanecz
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.